Free Trial

23,944 Shares in Option Care Health, Inc. $OPCH Bought by Cookson Peirce & Co. Inc.

Option Care Health logo with Medical background

Key Points

  • Cookson Peirce & Co. Inc. has acquired 23,944 shares of Option Care Health, Inc., valued at approximately $837,000, marking their entry into the company's stock during the first quarter.
  • Institutional investors hold a significant share of the company, with 98.05% of the stock owned by hedge funds and other institutions.
  • Option Care Health reported a 15.4% year-over-year increase in revenue during its last quarter, surpassing expectations with a revenue of $1.42 billion.
  • Need better tools to track Option Care Health? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Cookson Peirce & Co. Inc. acquired a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 23,944 shares of the company's stock, valued at approximately $837,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Public Employees Retirement System of Ohio boosted its position in Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after purchasing an additional 332 shares in the last quarter. Johnson Financial Group Inc. purchased a new position in shares of Option Care Health in the fourth quarter worth about $47,000. Bessemer Group Inc. raised its position in Option Care Health by 62.3% during the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after acquiring an additional 599 shares in the last quarter. Wealthquest Corp purchased a new position in Option Care Health during the first quarter valued at approximately $66,000. Finally, Farther Finance Advisors LLC raised its position in Option Care Health by 434.8% during the first quarter. Farther Finance Advisors LLC now owns 1,920 shares of the company's stock valued at $67,000 after acquiring an additional 1,561 shares in the last quarter. Institutional investors own 98.05% of the company's stock.

Option Care Health Price Performance

NASDAQ:OPCH traded up $0.21 during trading hours on Tuesday, reaching $28.40. 787,216 shares of the company traded hands, compared to its average volume of 1,833,099. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The firm's 50-day moving average is $30.22 and its 200-day moving average is $31.84. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The stock has a market cap of $4.61 billion, a P/E ratio of 22.75, a P/E/G ratio of 1.79 and a beta of 0.79.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same period last year, the company posted $0.30 EPS. The business's quarterly revenue was up 15.4% on a year-over-year basis. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Equities research analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on OPCH. Barrington Research restated an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research report on Thursday, July 10th. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and lifted their target price for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. JMP Securities lifted their target price on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. Finally, Citigroup restated an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat.com, Option Care Health currently has an average rating of "Moderate Buy" and an average target price of $35.75.

View Our Latest Analysis on Option Care Health

Option Care Health Company Profile

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

See Also

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

Should You Invest $1,000 in Option Care Health Right Now?

Before you consider Option Care Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.

While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines